Sinco Pharmaceuticals Holdings Limited

SEHK:6833 Stock Report

Market Cap: HK$498.1m

Sinco Pharmaceuticals Holdings Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Min Jin

Chief executive officer

CN¥1.7m

Total compensation

CEO salary percentage94.0%
CEO tenureless than a year
CEO ownership0.7%
Management average tenure2.2yrs
Board average tenure6.7yrs

Recent management updates

Recent updates

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

CEO Compensation Analysis

How has Min Jin's remuneration changed compared to Sinco Pharmaceuticals Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

CN¥27m

Mar 31 2023n/an/a

CN¥48m

Dec 31 2022CN¥2mCN¥2m

CN¥69m

Compensation vs Market: Min's total compensation ($USD229.49K) is about average for companies of similar size in the Hong Kong market ($USD234.61K).

Compensation vs Earnings: Insufficient data to compare Min's compensation with company performance.


CEO

Min Jin (45 yo)

less than a year

Tenure

CN¥1,659,000

Compensation

Mr. Min Jin was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since November 2020 until March 29, 2023. He has experience in the pharmaceutical industry. He served as Director of mar...


Leadership Team

NamePositionTenureCompensationOwnership
Xiangbin Huang
Executive Chairman12.9yrsCN¥4.11m51.65%
CN¥ 257.2m
Min Jin
Chief Executive Officerless than a yearCN¥1.66m0.67%
CN¥ 3.4m
Yifan Li
Chief Financial Officer8.8yrsno datano data
Shifeng Lei
Executive Directorno datano datano data
Yunlu Peng
Joint Company Secretary4.4yrsno datano data
Kin Wai Li
Joint Company Secretary3yrsno datano data
Tao Zhang
President of Sichuan Sinco Pharmaceuticals Co. Ltd.1.3yrsno datano data

2.2yrs

Average Tenure

43yo

Average Age

Experienced Management: 6833's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xiangbin Huang
Executive Chairman12.9yrsCN¥4.11m51.65%
CN¥ 257.2m
Shifeng Lei
Executive Directorless than a yearno datano data
Ying Kit Lau
Independent Non-Executive Director5.3yrsCN¥190.00kno data
Wenfang Liu
Independent Non-Executive Director8.1yrsCN¥190.00kno data
Qing Wang
Independent Non-Executive Director8.1yrsCN¥190.00kno data
Zhizhong Bai
Independent Non-Executive Director3.5yrsCN¥190.00kno data

6.7yrs

Average Tenure

57yo

Average Age

Experienced Board: 6833's board of directors are considered experienced (6.7 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.